GeneDx Holdings Corp vs Energy Select Sector SPDR Fund — how do they compare? GeneDx Holdings Corp trades at $86.53 (market cap $2.58B), while Energy Select Sector SPDR Fund trades at $65.64. The key difference: Energy Select Sector SPDR Fund is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| WGS | XLE | |
|---|---|---|
Market Cap | $2.58B | — |
Sector | Technology | — |
52-Week High | $167.51 | $65.31 |
52-Week Low | $34.51 | $42.61 |
Enterprise Value | $2.61B | — |
Signals from Pluang's Aura AI — not financial advice
WGS trades at $85.87, down 0.14% today, with a bullish technical signal from moving averages and support at $84. The company reported Q2 2026 revenue of $114.4M, beating estimates, and returned to adjusted profitability early. However, net income remains negative at -$106M for 2026, with high valuation multiples like EV/EBITDA of 161.17. Recent news highlights partnerships and product launches, such as the NPC GenomeComplete initiative with Beren Therapeutics.
Outlook is mixed: strong analyst buy consensus (90.9%) and institutional interest support upside, but profitability challenges and a class action lawsuit pose risks. Revenue growth and operational improvements are key catalysts, yet high debt-to-asset ratios and negative margins require monitoring for sustained recovery.
XLE, the Energy Select Sector SPDR ETF, trades at $64.78, up 1.12% amid bullish technical signals and strong sector momentum. The ETF benefits from rising oil prices, with Brent crude exceeding $100 per barrel due to Middle East tensions, as reported by Reuters on September 9, 2026. Technical indicators show a bullish moving average consensus, though the 6-day RSI at 78.15 suggests potential overbought conditions. Recent performance includes a 7.4% gain in August, leading sector ETFs, per ETF Trends on September 2, 2026.
Outlook remains positive driven by geopolitical supply risks and institutional optimism, with Goldman Sachs forecasting oil could reach $120 (Zacks, September 8, 2026). Key risks include oil price volatility and refining capacity constraints. The ETF's concentration in large caps like Exxon and Chevron offers stability, but investors face exposure to energy market cyclicality.
Trailing returns across standard periods
Latest headlines on both assets
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as energy companies by the GICS®, including securities of companies from the following industries: oil, gas and consumable fuels; and energy equipment and services. It is non-diversified.
Read more on XLE →